The Southern District of New York recently issued an opinion in a copyright suit involving a photo of celebrity rapper Cardi B. Photographer Rebecca Walsh sued Townsquare Media, Inc., alleging copyright infringement for Townsquare’s use, without a license, of one
Intellectual Property
AAM Renews Challenge to California’s Law Targeting Pharmaceutical Patent Infringement Settlements
On August 25, 2020, the Association for Accessible Medicines filed a new Complaint challenging California’s Assembly Bill 824 (“AB 824”). Enacted in October 2019 and in effect as of January 1, 2020, AB 824 imposes a presumption of anticompetitive effect…
New copyright registration option for bloggers; AT&T’s opinion on CDA §230; questions about YouTube’s anti-hate rules
A federal district court judge in Brooklyn, N.Y., dismissed the complaint in a case filed by Genius, a platform that lets users share and annotate lyrics, holding that the plaintiff’s claims were preempted by copyright law. The suit alleged…
Prosecution Pointer 241
Before you file in any foreign or international IP authority an application to protect an invention made in the United States, one must first obtain appropriate authorization from the USPTO. The ways such authorization may be obtained are: (1) filing…
Ninth Circuit: Under the “Asserted Truth Doctrine” (f/k/a “Copyright Estoppel”) Authors of Nonfiction Cannot Later Claim a Work is Fictional to Pursue a Copyright Case
In an opinion that will be of particular interest to writers, the Ninth Circuit has confirmed that authors of non-fiction works cannot later claim that elements of their work were, in fact, fictional in order to extend the scope of…
AIA Change Allows for Deceptive Patent Corrections
Amendment of § 256 Removed Previous Prohibition on Deceptive Intent
With the AIA, Congress amended § 256 to remove the requirement that the “error” of omitting an inventor from a patent must occur without “deceptive intention.” That is not to…
Junshi Biosciences to Study JS016, a Novel Coronavirus Neutralizing Antibody Product Candidate
In its second quarter earnings release, Junshi Biosciences announced that its product candidate JS016 was approved to conduct a Phase 1 clinical trial in China. The trial is a randomized, double-blind, placebo-controlled study to evaluate the tolerability and safety…
NeuClone Announces Active Development of Biosimilars Referencing OPDIVO and KEYTRUDA
On Sept. 1, 2020, NeuClone Pharmaceuticals announced that they are developing biosimilar candidates referencing OPDIVO and KEYTRUDA. According to NeuClone, the two biosimilar candidates “are in the advanced states of pre-clinical development.” This brings the number of NeuClone’s biosimilar pipeline…
Fortnite Creators Sued For Trademark Infringement Over Map
I’ve written previously about the relatively recent problem of video games reproducing real-life products and places and the potential for trademark infringement, at least in the minds of those companies who find their products in games that seek to replicate…
La Cour supérieure du Québec refuse d’émettre une ordonnance de type Norwich pour identifier le fournisseur de parfums sur le « marché gris »
Dans une décision récente, la Cour supérieure du Québec a refusé d’émettre une ordonnance contre un grossiste/détaillant permettant d’identifier les fournisseurs de produits de marque obtenus par l’entremise de l’importation parallèle et vendus au Québec sans l’autorisation du propriétaire de…